Infectious diseases are disorders caused by several
pathogenic organisms such as bacteria, viruses, fungi or parasites. These
diseases can be transmitted or spread from one person to another through direct
contact or indirect contact. Anti-infective drugs are used to treat or prevent
these infectious diseases by inhibiting the spread of an infectious agent
(static) or by killing the infectious agent (cidal).
Read More: https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-global-market-report-2018
The major reason
why the global anti-infective drugs market will increase from $117 billion in
2017 to $133 billion by 2021 is the growth of infectious diseases caused by
bacteria, viruses, fungi and the expected increase in global healthcare
expenditure.
In the report,
the global anti-infective drugs market is divided into four segments, namely
antivirals, antibiotics, antifungals and others (antihelmethic, antiprotozoal).
While the first segment accounts for more than half of the market share, the
remaining share is attributed to the other three segments.
The
USA was the largest country in the anti-infective drugs market in 2017,
accounting for nearly one-fourth of the market share. This can be attributed to
the increased healthcare expenditure per capita in the country and the
availability of a wide network of healthcare facilities. China and Italy
followed the USA as the next largest countries in the market.
The
anti-infective drugs market is fragmented into a number of large and small
organizations. The top five competitors in the market made up around 30% of the
total market in 2017. Gilead Sciences, Inc. was the largest competitor of the
market, followed by Merck & Co. and GlaxoSmithKline Plc. Gilead is an
American biopharmaceutical company that discovers, develops and commercializes
therapeutics for areas such as cardiovascular and inflammation/respiratory
diseases, hematology/oncology, human immunodeficiency virus (HIV), liver
diseases such as chronic hepatitis C virus (HCV) infection and chronic
hepatitis B virus (HBV) infection. The company was founded in 1987 and is
headquartered in Foster City, California, United States.
About The
Business Research Company.
The Business
Research Company is a Business Intelligence Company which excels in company,
market and consumer research. It has offices in
the UK, the US and India and a network of trained researchers in 15 countries
globally.
Contact
Information.
The Business Research Company
Europe: +44 207
1930 708
Asia: +91
8897263534
Americas: +1 315
623 0293
No comments:
Post a Comment